EG19995A - Method for preparing of stabilized PVP_1 solutions - Google Patents

Method for preparing of stabilized PVP_1 solutions

Info

Publication number
EG19995A
EG19995A EG39192A EG39192A EG19995A EG 19995 A EG19995 A EG 19995A EG 39192 A EG39192 A EG 39192A EG 39192 A EG39192 A EG 39192A EG 19995 A EG19995 A EG 19995A
Authority
EG
Egypt
Prior art keywords
solution
pvp
preparing
solutions
standards
Prior art date
Application number
EG39192A
Other languages
English (en)
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Application granted granted Critical
Publication of EG19995A publication Critical patent/EG19995A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/18Iodine; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • A61K31/787Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79Polymers of vinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Lubricants (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Hydrogenated Pyridines (AREA)
EG39192A 1991-07-16 1992-07-14 Method for preparing of stabilized PVP_1 solutions EG19995A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/730,462 US5126127A (en) 1991-07-16 1991-07-16 Stabilized PVP-I solutions

Publications (1)

Publication Number Publication Date
EG19995A true EG19995A (en) 1997-01-30

Family

ID=24935466

Family Applications (1)

Application Number Title Priority Date Filing Date
EG39192A EG19995A (en) 1991-07-16 1992-07-14 Method for preparing of stabilized PVP_1 solutions

Country Status (16)

Country Link
US (1) US5126127A (no)
EP (1) EP0526695B1 (no)
JP (1) JP3531945B2 (no)
KR (1) KR100191873B1 (no)
AT (1) ATE163130T1 (no)
AU (1) AU646745B2 (no)
CA (1) CA2062001C (no)
DE (1) DE69224416T2 (no)
DK (1) DK0526695T3 (no)
EG (1) EG19995A (no)
ES (1) ES2111581T3 (no)
FI (1) FI114443B (no)
IE (1) IE920796A1 (no)
IL (1) IL101079A (no)
NO (1) NO306379B1 (no)
ZA (1) ZA921365B (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2685892A (en) * 1991-10-08 1993-05-03 Isp Investments Inc. Method of treating blood
GB9306296D0 (en) * 1993-03-26 1993-05-19 Diversey Corp Improved iodophors,production and use thereof
DE9312509U1 (de) * 1993-08-20 1993-10-28 Euro-Celtique S.A., Luxemburg/Luxembourg Präparate zur äußeren Verabreichung von antiseptischen und/oder die Wundheilung fördernden Wirkstoffen
JP3108262B2 (ja) * 1993-12-22 2000-11-13 明治製菓株式会社 研磨剤を含有しない口腔用半練状製剤
US6605110B2 (en) 2001-06-29 2003-08-12 Advanced Cardiovascular Systems, Inc. Stent with enhanced bendability and flexibility
ES2292874T3 (es) 2003-05-19 2008-03-16 Euro-Celtique S.A. Composiciones liposomales secas de pvp-yodo.
US20050262811A1 (en) * 2004-05-27 2005-12-01 Mahmood Mohiuddin Sterilization process for iodine-containing antimicrobial topical solutions
US7767217B2 (en) * 2006-03-14 2010-08-03 Foresight Biotherapeutics Ophthalmic compositions comprising povidone-iodine
AU2016253668B2 (en) * 2006-03-14 2018-12-06 Cls Pharmaceuticals, Inc. Ophthalmic compositions comprising povidone-iodine
AU2013203462B2 (en) * 2006-03-14 2016-08-04 Cls Pharmaceuticals, Inc. Ophthalmic compositions comprising povidone-iodine
JP5083502B2 (ja) * 2006-12-25 2012-11-28 ライオン株式会社 眼科用組成物
US20080172032A1 (en) * 2007-01-11 2008-07-17 James Pitzer Gills Method for preventing tissue damage associated with irrigation of tissue with an antimicrobial solution
NZ747878A (en) * 2008-06-12 2020-07-31 Foresight Biotherapeutics Inc Povidone iodine, a novel alternative preservative for ophthalmic compositions
KR20120112537A (ko) * 2009-12-15 2012-10-11 포어사이트 바이오쎄라퓨틱스, 인코퍼레이티드 무자극성 안과용 포비돈-요오드 조성물
JP5367597B2 (ja) 2010-01-18 2013-12-11 株式会社オフテクス コンタクトレンズ洗浄用有核錠及びそれを含むコンタクトレンズ洗浄用製剤、並びにコンタクトレンズ洗浄方法
GB201114725D0 (en) * 2011-08-25 2011-10-12 Altacor Ltd Ophthalmic formulations
TW201808311A (zh) * 2011-09-16 2018-03-16 遠景生物製藥股份有限公司 安定之普維酮-碘組成物
DK2895144T3 (en) 2012-09-12 2017-03-06 Novaliq Gmbh SEMIFLUORED ALKAN COMPOSITIONS
EP3100722B1 (en) 2012-09-12 2024-03-20 Novaliq GmbH Semifluorinated alkanes for use in solubilizing meibum
US20180200289A1 (en) * 2015-07-02 2018-07-19 Veloce Biopharma, Llc Novel ophthalmic composition and methods of use
US9770466B2 (en) 2015-07-02 2017-09-26 Veloce Biopharma, Llc Ophthalmic composition and methods of use
ES2957559T3 (es) 2017-04-21 2024-01-22 Dermaliq Therapeutics Inc Composiciones de yodo
IT201700068170A1 (it) * 2017-06-20 2018-12-20 Iromed Group S R L Composizione disinfettante per uso oftalmico
EP3672572A4 (en) * 2017-08-22 2021-01-06 Veloce BioPharma, LLC NOVEL OPHTHALMIC COMPOSITION AND METHOD OF USE
JP6941889B2 (ja) 2017-09-02 2021-09-29 アイビュー セラピューティクス、インコーポレイテッド インサイチュゲル形成医薬組成物および副鼻腔疾患のためのその使用
KR20200081160A (ko) 2018-12-27 2020-07-07 유한회사 플루켐 염화나트륨 함유 포비돈 요오드 안정 조성물 및 방법
AU2020280226A1 (en) 2019-06-10 2022-01-06 Firebrick Pharma Limited Prevention of infection by highly pathogenic viruses using topical application of povidone-iodine on mucous membranes
JP2022546275A (ja) * 2019-08-18 2022-11-04 アイビュー セラピューティクス,インコーポレイテッド 希釈ポビドンヨード製剤を含む安定した医薬品
BR112022024381A2 (pt) * 2020-06-10 2022-12-27 Firebrick Pharma Ltd Formulações virucidas aperfeiçoadas
AU2021203846B2 (en) * 2021-06-10 2022-11-24 Firebrick Pharma Limited Virucidal formulations containing povidone-iodine
KR102434736B1 (ko) 2021-11-04 2022-08-23 (주)씨에스하이테크플러스 신재생에너지를 이용한 에너지자립형 냉난방 시스템 및 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7902893L (sv) * 1979-04-02 1980-10-03 Astra Chem Prod Ab Desinfektionsmedel
US4364929A (en) * 1979-04-02 1982-12-21 The Purdue Frederick Company Germicidal colloidal lubricating gels and method of producing the same
US4401651A (en) * 1979-04-18 1983-08-30 Knutson Richard A Wound-healing compositions containing povidone-iodine
US4526751A (en) * 1983-12-09 1985-07-02 Gartner William J Germicidal solutions effective for solid surface disinfection
WO1989000044A1 (en) * 1987-07-07 1989-01-12 Santen Pharmaceutical Co., Ltd. Artificial lacrima
CA1303503C (en) * 1987-11-10 1992-06-16 Marc Plamondon Ophthalmic solution comprising iodine-polyvinylpyrrolidone complex
US5034230A (en) * 1987-12-25 1991-07-23 Santen Pharmaceutical Co., Ltd. Anti-allergic ophthalmics
US4939272A (en) * 1989-05-05 1990-07-03 Gaf Chemicals Corporation Water soluble complexes of polyvinylpyrrolidone, hydrogen chloride and iodine and process for making the same
NL9002049A (nl) * 1990-09-18 1992-04-16 Dagra Pharma Bv Oogheelkundig preparaat dat een povidon-joodoplossing bevat.

Also Published As

Publication number Publication date
EP0526695A1 (en) 1993-02-10
DE69224416T2 (de) 1998-07-30
IL101079A (en) 1997-01-10
IE920796A1 (en) 1993-01-27
IL101079A0 (en) 1992-11-15
NO922793D0 (no) 1992-07-15
DK0526695T3 (da) 1998-09-23
JP3531945B2 (ja) 2004-05-31
ES2111581T3 (es) 1998-03-16
FI922906A0 (fi) 1992-06-22
US5126127A (en) 1992-06-30
NO922793L (no) 1993-01-18
DE69224416D1 (de) 1998-03-19
FI114443B (fi) 2004-10-29
EP0526695B1 (en) 1998-02-11
KR930001914A (ko) 1993-02-22
CA2062001C (en) 1999-03-02
FI922906A (fi) 1993-01-17
AU1942792A (en) 1994-01-13
NO306379B1 (no) 1999-11-01
KR100191873B1 (ko) 1999-06-15
ZA921365B (en) 1992-11-25
AU646745B2 (en) 1994-03-03
CA2062001A1 (en) 1993-01-17
JPH0570356A (ja) 1993-03-23
ATE163130T1 (de) 1998-02-15

Similar Documents

Publication Publication Date Title
EG19995A (en) Method for preparing of stabilized PVP_1 solutions
EP0295903A3 (en) Hair preparation
NO174795C (no)
NO902487D0 (no) Vandig folinatloesning stabil ved kjoeleskapstemperatur og fremgangsmaate ved fremstilling derav.
HU9200948D0 (en) Process for the stabilization of waterless suspensions
ZA879458B (en) Medicaments
IE893810L (en) Stabilizing packaged iodophor and minimizing leaching of¹iodine through packaging
FI902713A0 (fi) Menetelmä stabiilin karboplatiinivesiliuoksen valmistamiseksi
GR3015925T3 (en) An ophthalmic preparation comprising a povidone-iodine solution.
AU8295587A (en) Nasal solutions
GB9104968D0 (en) Pharmaceutical iodine composition
CA2057493A1 (en) A process for the preparation of a pasteurized and iron-free human transferrin
ZA954274B (en) Process for preparing 4,4'-dinitrostilbene-2,2'-disulphonic acid and its salts
GR3036822T3 (en) Eye lotion in particular for dry eye treatment
PT82165A (en) Auxiliary device for the application of eye-drops
AU4408685A (en) Appareil articule d'aide a la marche
AU551407B2 (en) Crystalline human leukocyte interferon
GR3015853T3 (en) Procedure for disinfecting and cleaning contact lenses.